Organo-ID
1 known investors
Organo-ID develops iPSC-derived organoid systems, including 3D hepatocyte models, to test drugs in better-modeled biological systems for predictive diagnostics and personalized therapies. The company serves drug development and treatment applications in oncology and rare disease, operating from Turkey with a global focus.
BiotechDeep TechDigital HealthMedical Devices
Founders & leadership
PD
Prof. Dr. Erdal
BA
Bugraer AslanCo-founder & CEO
EE
Esra ErdalCo-founder & Chief Scientific Officer
Investors · 1
Frequently asked questions
- What does Organo-ID do?
- Organo-ID develops iPSC-derived organoid systems, including 3D hepatocyte models, to test drugs in better-modeled biological systems for predictive diagnostics and personalized therapies. The company serves drug development and treatment applications in oncology and rare disease, operating from Turkey with a global focus.
- Who founded Organo-ID?
- Organo-ID was founded by Prof. Dr. Erdal, Bugraer Aslan, Esra Erdal.
- Who are Organo-ID's investors?
- Organo-ID's investors include Idacapital.